This computational study models how two simultaneous zeitgebers (light and a Rev-Erb drug) interact to entrain the mammalian circadian clock. The phase difference between the two zeitgebers critically determines entrainment range, amplitude, and speed of synchronization, with synergistic phase differences producing broader entrainment and faster recovery from perturbations. These findings suggest that optimizing the timing of drug administration relative to light cycles could strengthen disrupted circadian rhythms in clinical settings such as cancer or ICU patients.